Skip to content
Menu

Repligen Raises FY2026 Adj EPS Guidance from $2.03-$2.09 to $2.05-$2.09 vs $2.06 Est; Raises FY2026 Sales Guidance from $813.000M-$835.000M to $844.000M-$852.000M vs $829.693M Est

Benzinga Newsdesk 3 weeks ago

NewsGuidance

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Repligen (NASDAQ:RGEN) raises FY2026 Adj EPS guidance from $2.03-$2.09 to $2.05-$2.09 vs $2.06 analyst estimate. Raises FY2026 sales outlook from $813.000 million-$835.000 million to $844.000 million-$852.000 million vs

Repligen (NASDAQ:RGEN) raises FY2026 Adj EPS guidance from $2.03-$2.09 to $2.05-$2.09 vs $2.06 analyst estimate. Raises FY2026 sales outlook from $813.000 million-$835.000 million to $844.000 million-$852.000 million vs $829.693 million estimate.

Read at benzinga.com